Preclinical applications of imaging for cancer gene therapy

Expert Reviews in Molecular Medicine

Volumn 8, Issue 16, 2006, Pages 1-19

  Briat, Arnaud ^a   Vassaux, Georges ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 FLUOROETHYL)SPIPERONE F 18; 9 (3 FLUORO 1 HYDROXY 2 PROPOXYMETHYL)GUANINE; ADENOVIRUS VECTOR; CYTOSINE DEAMINASE; DOPAMINE 2 RECEPTOR; FIALURIDINE; FLUORINE 18; FLUOROCHROME; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; GUANINE DERIVATIVE; INTERLEUKIN 2; IODINE 123; IODINE 124; IODINE 125; IODINE 131; LUCIFERASE; LUCIFERIN; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; ONCOLYTIC VIRUS; PENCICLOVIR; PENTETREOTIDE IN 111; PERTECHNETIC ACID TC 99M; RHENIUM 186; RHENIUM 188; SODIUM IODIDE SYMPORTER; SOMATOSTATIN RECEPTOR 2; TECHNETIUM 99M; THYMIDINE KINASE; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIFIDOBACTERIUM; BIOLUMINESCENCE; CANCER CELL; CLOSTRIDIUM; ESCHERICHIA COLI; FLUORESCENCE ANALYSIS; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE THERAPY; GENE VECTOR; GENETIC ANALYSIS; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; IMAGE DISPLAY; IMAGE RECONSTRUCTION; IMAGING SYSTEM; IN VIVO STUDY; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REPORTER GENE; REVIEW; SALMONELLA; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNOLOGY; THREE DIMENSIONAL IMAGING; TRANSGENE; TREATMENT OUTCOME; VIBRIO; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CLINICAL TRIALS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33746079211     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399406000044     Document Type: Review

References (99)

1. Okada, Y. et al. (2005) Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma. Cancer Gene Ther 12, 608-616
2. Wang, H. et al. (2005) Treatment of hepatocellular carcinoma with adenoviral vector-mediated Flt3 ligand gene therapy. Cancer Gene Ther 12, 769-777
3. Khuri, F.R. et al. (2000) a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 6, 879-885
4. Sandmair, A.M. et al. (2000) Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Hum Gene Ther 11, 2197-2205
5. Nemunaitis, J. et al. (2000) Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol 18, 609-622
6. Isner, J.M. and Asahara, T. (1999) Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103, 1231-1236
7. Soghomonyan, S.A. et al. (2005) Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK. Cancer Gene Ther 12, 101-108
8. Bogdanov, A., Jr. and Weissleder, R. (1998) The development of in vivo imaging systems to study gene expression. Trends Biotechnol 16, 5-10
9. Vassaux, G. and Groot-Wassink, T. (2003) In Vivo Noninvasive Imaging for Gene Therapy. J Biomed Biotechnol 2003, 92-101
10. Brix, G. et al. (1996) Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: A comparative animal study. Nucl Med Biol 23, 897-906
11. Gambhir, S.S. et al. (1999) Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol 26, 481-490
12. Blasberg, R.G. and Tjuvajev, J.G. (1999) Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. Q J Nucl Med 43, 163-169
13. Iyer, M. et al. (2001) 8-[18F]Fluoropenciclovir: An improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med 42, 96-105
14. Gambhir, S.S. et al. (2000) A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A 97, 2785-2790
15. Liang, Q. et al. (2001) Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 8, 1490-1498
16. Yaghoubi, S.S. et al. (2001) Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther 8, 1072-1080
17. MacLaren, D.C. et al. (1999) Repetitive, noninvasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6, 785-791
18. Hemminki, A. et al. (2002) In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. J Natl Cancer Inst 94, 741-749
19. Zinn, K.R. and Chaudhuri, T.R. (2002) The type 2 human somatostatin receptor as a platform for reporter gene imaging. Eur J Nucl Med Mol Imaging 29, 388-399
20. Chaudhuri, T.R. et al. (2001) A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecol Oncol 83, 432-438
21. Pages, P. et al. (1999) sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1. J Biol Chem 274, 15186-15193
22. Rochaix, P. et al. (1999) Gene therapy for pancreatic carcinoma: Local and distant antitumor effects after somatostatin receptor sst2 gene transfer. Hum Gene Ther 10, 995-1008
23. Benali, N. et al. (2000) Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A 97, 9180-9185
24. Dingli, D., Russell, S.J. and Morris, J.C., 3rd (2003) In vivo imaging and tumor therapy with the sodium iodide symporter. J Cell Biochem 90, 1079-1086
25. Filetti, S. et al. (1999) Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 141, 443-457
26. Dadachova, E. and Carrasco, N. (2004) The Na/I symporter (NIS): Imaging and therapeutic applications. Semin Nucl Med 34, 23-31
27. Dai, G., Levy, O. and Carrasco, N. (1996) Cloning and characterization of the thyroid iodide transporter. Nature 379, 458-460
28. Shimura, H. et al. (1997) Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene. Endocrinology 138, 4493-4496
29. Meykadeh, N. et al. (2005) Topical application of plasmid DNA to mouse and human skin. J Mol Med 83, 897-903
30. Bertoni, C. et al. (2006) Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proc Natl Acad Sci U S A 103, 419-424
31. Vassaux, G. et al. (2006) Bacterial gene therapy strategies. J Pathol 208, 290-298
32. Li, C. et al. (2005) Adeno-associated virus vectors: Potential applications for cancer gene therapy Cancer Gene Ther 12, 913-925
33. Lotze, M.T. and Kost, T.A. (2002) Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther 9, 692-699
34. Shah, K. et al. (2004) Molecular imaging of gene therapy for cancer. Gene Ther 11, 1175-1187
35. Green, N.K. and Seymour, L.W. (2002) Adenoviral vectors: Systemic delivery and tumor targeting. Cancer Gene Ther 9, 1036-1042
36. Dehari, H. et al. (2003) Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer. Cancer Gene Ther 10, 75-85
37. Robson, T. and Hirst, D.G. (2003) Transcriptional Targeting in Cancer Gene Therapy. J Biomed Biotechnol 2003, 110-137
38. Zhu, Z.B. et al. (2004) Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Cancer Gene Ther 11, 256-262
39. Groot-Wassink, T. et al. (2004) Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice. Cancer Res 64, 4906-4911
40. Oosterhoff, D. et al. (2005) Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24. Gene Ther 12, 1011-1018
41. Kanerva, A. et al. (2005) Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus. Gene Ther 12, 87-94
42. Faivre, J. et al. (2004) Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats. Cancer Res 64, 8045-8051
43. Reader, A.J. and Zweit, J. (2001) Developments in whole-body molecular imaging of live subjects. Trends Pharmacol Sci 22, 604-607
44. Budinger, T.F. (1998) PET instrumentation: What are the limits? Semin Nucl Med 28, 247-267
45. Juweid, M.E. and Cheson, B.D. (2006) Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354, 496-507
46. Jacobs, A.H. et al. (2002) Molecular imaging of gliomas. Mol Imaging 1, 309-335
47. Tjuvajev, J.G. et al. (1996) Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res 56, 4087-4095
48. Jacobs, A.H. et al. (2003) Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Hum Gene Ther 14, 277-297
49. Jacobs, A. et al. (2001) Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res 61, 2983-2995
50. Chatziioannou, A.F. (2005) Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT. Proc Am Thorac Soc 2, 533-536, 510-511
51. Chatziioannou, A.F. (2002) PET scanners dedicated to molecular imaging of small animal models. Mol Imaging Biol 4, 47-63
52. Chatziioannou, A. et al. (2001) Detector development for microPET II: A 1 microl resolution PET scanner for small animal imaging. Phys Med Biol 46, 2899-2910
53. Chatziioannou, A.F. et al. (1999) Performance evaluation of microPET: A high resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med 40, 1164-1175
54. Yaghoubi, S.S. et al. (2005) Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Ther 12, 329-339
55. Doubrovin, M. et al. (2001) Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci U S A 98, 9300-9305
56. el-Deiry, W.S. (1998) Regulation of p53 downstream genes. Semin Cancer Biol 8, 345-357
57. Hollstein, M. et al. (1991) p53 mutations in human cancers. Science 253, 49-53
58. Bogdanov, A.A., Lewin, M. and Weissleder, R. (1999) Approaches and agents for imaging the vascular system. Adv Drug Deliv Rev 37, 279-293
59. Schellingerhout, D. et al. (2000) Quantitation of HSV mass distribution in a rodent brain tumor model. Gene Ther 7, 1648-1655
60. Kim, K.I. et al. (2005) Visualization of endogenous p53-mediated transcription in vivo using sodium iodide symporter. Clin Cancer Res 11, 123-128
61. Ishizu, K. et al. (1995) Ultra-high resolution SPECT system using four pinhole collimators for small animal studies. J Nucl Med 36, 2282-2287
62. Beekman, F.J. et al. (2005) U-SPECT-I: A novel system for submillimeter-resolution tomography with radiolabeled molecules in mice. J Nucl Med 46, 1194-1200
63. Goertzen, A.L. et al. (2005) First results from the high-resolution mouseSPECT annular scintillation camera. IEEE Trans Med Imaging 24, 863-867
64. Contag, P.R. et al. (1998) Bioluminescent indicators in living mammals. Nat Med 4, 245-247
65. Johnson, G.A. et al. (2002) Magnetic resonance histology for morphologic phenotyping. J Magn Reson Imaging 16, 423-429
66. Weissleder, R. (2002) Scaling down imaging: Molecular mapping of cancer in mice. Nat Rev Cancer 2, 11-18
67. Jacobs, R.E. and Fraser, S.E. (1994) Magnetic resonance microscopy of embryonic cell lineages and movements. Science 263, 681-684
68. Smith, B.R. et al. (1994) Magnetic resonance microscopy of mouse embryos. Proc Natl Acad Sci U S A 91, 3530-3533
69. Moore, A. et al. (1998) Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta 1402, 239-249
70. Shen, T. et al. (1993) Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 29, 599-604
71. Zimmer, C. et al. (1997) Tumor cell endocytosis imaging facilitates delineation of the glioma-brain interface. Exp Neurol 143, 61-69
72. Moore, A. et al. (2001) Human transferrin receptor gene as a marker gene for MR imaging. Radiology 221, 244-250
73. Genove, G. et al. (2005) A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11, 450-454
74. Weissleder, R. et al. (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6, 351-355
75. Contag, C.H. and Bachmann, M.H. (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4, 235-260
76. Chalfie, M. et al. (1994) Green fluorescent protein as a marker for gene expression. Science 263, 802-805
77. Becker, A. et al. (2001) Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 19, 327-331
78. Ntziachristos, V. et al. (2005) Looking and listening to light: The evolution of whole-body photonic imaging. Nat Biotechnol 23, 313-320
79. Ntziachristos, V. et al. (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8, 757-760
80. Sweeney, T.J. et al. (1999) Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A 96, 12044-12049
81. Bhaumik, S. and Gambhir, S.S. (2002) Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci U S A 99, 377-382
82. Nakajima, A. et al. (2001) Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 107, 1293-1301
83. Lipshutz, G.S. et al. (2001) In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long term expression. Mol Ther 3, 284-292
84. Zuckier, L.S. et al. (2004) Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. J Nucl Med 45, 500-507
85. Groot-Wassink, T. et al. (2002) Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 13, 1723-1735
86. Dingli, D. et al. (2004) Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochem Biophys Res Commun 325, 157-166
87. Siegel, E. (1999) The beginnings of radioiodine therapy of metastatic thyroid carcinoma: A memoir of Samuel M. Seidlin, M. D. (1895-1955) and his celebrated patient. Cancer Biother Radiopharm 14, 71-79
88. Spitzweg, C. et al. (2001) Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 86, 3327-3335
89. Smit, J.W. et al. (2002) Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line. J Clin Endocrinol Metab 87, 1247-1253
90. Spitzweg, C. et al. (2000) Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res 60, 6526-6530
91. Spitzweg, C. et al. (2001) In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther 8, 1524-1531
92. Spitzweg, C. et al. (1998) Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 83, 1746-1751
93. Ajjan, R.A. et al. (1998) Regulation and tissue distribution of the human sodium iodide symporter gene. Clin Endocrinol (Oxf) 49, 517-523
94. Marsee, D.K. et al. (2004) Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Ther 11, 121-127
95. Groot-Wassink, T. et al. (2004) Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther 9, 436-442
96. Kakinuma, H. et al. (2003) Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res 63, 7840-7844
97. Jacobs, A. et al. (2001) Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358, 727-729
98. Colombo, F. et al. (2005) Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: Biological and clinical results. Cancer Gene Ther 12, 835-848
99. Penuelas, I. et al. (2005) Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 128, 1787-1795